Sanjeev A. Vasudevan, M.D.
Pediatric Surgery Service,
Texas Children’s Hospital
Assistant Professor of Surgery
Department of Surgery,
Pediatric Surgery Division
Baylor College of Medicine
Dr. Sanjeev Vasudevan
6701 Fannin St., Ste. 1210
Houston, TX 77030
Dr. Sanjeev Vasudevan is a pediatric surgeon who specializes in pediatric surgical oncology. In addition to performing general neonatal and pediatric surgery, he is a member of the Surgical Oncology Team at Texas Children’s Hospital and is actively involved with taking care of patients with neuroblastoma, liver cancer, renal tumors, and sarcomas. His research program consists of clinical and molecular biology research focusing on pediatric solid tumors, in particular neuroblastoma and liver cancer. He is a member of the Carl C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation Laboratory for Neuroblastoma Research as well as the Texas Children’s Liver Tumor Center.
Member, Phi Beta Kappa
Associate Member, American Association for Cancer Research
Resident and Associate Society Member, American College of Surgeons
American Board of Surgery, Pediatric Surgery
American Board of Pediatrics
Pediatric Surgery Residency, Baylor College of Medicine, Texas Children’s Hospital
Research Fellowship, Molecular Cancer Biology, Baylor College of Medicine, Texas Children’s Cancer Center
General Surgery Residency, Baylor College of Medicine
M.D., Emory University School of Medicine, Atlanta, GA
Dr. Sanjeev Vasudevan’s research laboratory focuses on validation of potential therapeutic targets found in neuroblastoma and hepatoblastoma. During his postdoctoral training in the Texas Children’s Cancer Center, Dr. Vasudevan cloned two novel genes, NDSP and DUSP26, which were found to be specifically overexpressed in neuroblastoma and play critical roles in tumor growth and chemosensitivity. He is furthering this work as a principal investigator by focusing on the function and regulation of kinases and phosphatases in pediatric malignancy by defining their roles as novel tumor suppressors or oncogenes. Dr. Vasudevan’s lab hopes to validate multiple targets in order to find novel and less toxic therapeutic agents to improve outcomes for children with solid tumors.
He is a member of the Carl C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation Laboratory for Neuroblastoma Research.